Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimo Dietrich

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Anticancer Research|December 7, 2016
Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma PatientsSebastian Meller, Anne VAN Ellen, Heidrun Gevensleben, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Comparative Performance of agentic AI and Physicians in Taking Clinical History across Leading Large Language Models (LLMs)Sophie Steinbuch, Luka de Vos-Hillebrand, Connor O'Neill-Dee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 21, 2022
CTLA4 , PD-1 , PD-L1 , PD-L2 , TIM-3 , TIGIT , and LAG3 DNA Methylation Is Associated With BAP1 -Aberrancy, Transcriptional Activity, and Overall Survival in Uveal MelanomaLuka de Vos, Tzaitel Maria Carrillo Cano, Romina Zarbl, et al.
Clinical Epigenetics|April 12, 2022
DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapyDennis Niebel, Anne Fröhlich, Romina Zarbl, et al.
International Journal of Oncology|November 24, 2011
Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspiratesDimo Dietrich, Christoph Kneip, Olaide Raji, et al.
BMC Cancer|March 24, 2011
Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumorsKatja U Schneider, Dimo Dietrich, Michael Fleischhacker, et al.
Virchows Archiv : an International Journal of Pathology|August 31, 2014
Myoglobin expression in prostate cancer is correlated to androgen receptor expression and markers of tumor hypoxiaSebastian Meller, Anne Bicker, Matteo Montani, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 5, 2025
Integrating fecal immunochemical testing and methylated SEPT9 for enhanced colorectal cancer Screening: A Multi-Center Case-Control studyJonas Dohmen, Stefanie Rohrbach, Tim Vilz, et al.
ACS Nano|November 5, 2021
Targeting Cancer Chemotherapy Resistance by Precision Medicine-Driven Nanoparticle-Formulated CisplatinSvenja Siemer, Tobias A Bauer, Paul Scholz, et al.
Ebiomedicine|February 7, 2020
Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanomaAnne Fröhlich, Sophia Loick, Emma Grace Bawden, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Anticancer Research|December 7, 2016
Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma PatientsSebastian Meller, Anne VAN Ellen, Heidrun Gevensleben, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Comparative Performance of agentic AI and Physicians in Taking Clinical History across Leading Large Language Models (LLMs)Sophie Steinbuch, Luka de Vos-Hillebrand, Connor O'Neill-Dee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 21, 2022
CTLA4 , PD-1 , PD-L1 , PD-L2 , TIM-3 , TIGIT , and LAG3 DNA Methylation Is Associated With BAP1 -Aberrancy, Transcriptional Activity, and Overall Survival in Uveal MelanomaLuka de Vos, Tzaitel Maria Carrillo Cano, Romina Zarbl, et al.
Clinical Epigenetics|April 12, 2022
DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapyDennis Niebel, Anne Fröhlich, Romina Zarbl, et al.
International Journal of Oncology|November 24, 2011
Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspiratesDimo Dietrich, Christoph Kneip, Olaide Raji, et al.
BMC Cancer|March 24, 2011
Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumorsKatja U Schneider, Dimo Dietrich, Michael Fleischhacker, et al.
Virchows Archiv : an International Journal of Pathology|August 31, 2014
Myoglobin expression in prostate cancer is correlated to androgen receptor expression and markers of tumor hypoxiaSebastian Meller, Anne Bicker, Matteo Montani, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 5, 2025
Integrating fecal immunochemical testing and methylated SEPT9 for enhanced colorectal cancer Screening: A Multi-Center Case-Control studyJonas Dohmen, Stefanie Rohrbach, Tim Vilz, et al.
ACS Nano|November 5, 2021
Targeting Cancer Chemotherapy Resistance by Precision Medicine-Driven Nanoparticle-Formulated CisplatinSvenja Siemer, Tobias A Bauer, Paul Scholz, et al.
Ebiomedicine|February 7, 2020
Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanomaAnne Fröhlich, Sophia Loick, Emma Grace Bawden, et al.
Pageof 12